Illustrations in gynaecology: still controversial?
نویسندگان
چکیده
منابع مشابه
Ameloblastoma: a still controversial tumour.
This is a review of 20 cases of ameloblastomas diagnosed and treated at the Dental Facu ltv, University of Malaya, Kuala Lumpur. The clinical features, histological features and treatment methods are presented. Two basic clinical types namely the conventional (solid/multicystic) and unicystic ameloblastomas showed different recurrence rates. Discrepancies between the recurrent rates in this stu...
متن کاملIron hypothesis of cardiovascular disease: still controversial.
Iron hypothesis has been a controversial subject for over 30 years as many studies support its role as a risk factor for cardiovascular disease, while other studies found no evidence to support it. The conflicting results are accounted for by the non-homogeneity of trial design in terms of population inclusion criteria and different endpoints, non-uniform use of parameters for assessing iron ro...
متن کاملIs closure of atrial septal defects in adults still controversial?
We would like to thank T. Ebels for taking interest in our manuscript in an editorial comment and are happy to further elaborate on our view regarding the closure of atrial septal defects in adults [1,2]. We agree with T. Ebels that defining which patients to treat— with regard to shunt size, defect size and haemodynamic importance—is an interesting and difficult task. He questioned how our pat...
متن کاملSecond-Line Chemotherapy in Recurrent Glioblastoma--Still Controversial.
studies, providing an important benchmark for future trials. Data about the combination of bevacizumab and lomustine were also considered worthy of further investigation in a phase III study, and the EORTC re-designed a randomized study with the aim to compare lomustine alone versus a combination of lomustine and bevacizumab. The results of the study of Carvalho et al. [1] are in line with what...
متن کاملRole of interferon-alfa in NHL: still controversial?
Recombinant interferon-alfa (Intron A, Roferon-A) has been under investigation as a therapeutic agent for non-Hodgkin's lymphoma (NHL) for 25 years. It has antitumor efficacy in a number of histologic subtypes but has not been accepted as a clinically useful agent by the majority of oncologists/hematologists. A total of 10 prospective, randomized trials of interferon-alfa have been conducted in...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Gynecological Surgery
سال: 2005
ISSN: 1613-2076,1613-2084
DOI: 10.1007/s10397-005-0100-1